The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.
作者信息
Baheerathan Aravindhan, McNamara Cillian, Kalam Sabrina, Rane Neil, Barwick Tara D, Grote Helen, Nicholas Richard
机构信息
From the Departments of Neurology (A.B., S.K., H.G., R.N.), Neuroradiology (C.M., N.R.), and Nuclear Medicine (T.D.B.), Charing Cross Hospital, Imperial College NHS Trust, London, UK.
出版信息
Neurology. 2018 Sep 18;91(12):572-573. doi: 10.1212/WNL.0000000000006213.
Abstract
摘要
相似文献
1
The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.18F-氟代脱氧葡萄糖正电子发射断层显像（FDG-PET）成像在鉴别接受那他珠单抗治疗的患者中进行性多灶性白质脑病合并免疫重建炎症综合征（PML-IRIS）与进行性多灶性白质脑病（PML）方面的效用
Neurology. 2018 Sep 18;91(12):572-573. doi: 10.1212/WNL.0000000000006213.
2
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.多发性硬化症患者接受那他珠单抗治疗后出现早期 PML-IRIS 的 MRI 特征。
J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):879-84. doi: 10.1136/jnnp-2015-311411. Epub 2015 Sep 14.
3
Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS.炎症性依那西普相关进行性多灶性白质脑病：基线特征、病变演变及与 PML-IRIS 的关系。
J Neurol Neurosurg Psychiatry. 2018 May;89(5):535-541. doi: 10.1136/jnnp-2017-316886. Epub 2017 Nov 15.
4
Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.接受那他珠单抗治疗的多发性硬化症患者的免疫重建炎症综合征：4例病例系列
Clin Ther. 2016 Mar;38(3):670-5. doi: 10.1016/j.clinthera.2016.01.010. Epub 2016 Feb 5.
5
Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.临床无症状的 PML 和多发性硬化症患者接受那他珠单抗治疗后的免疫重建炎症综合征延长。
Mult Scler. 2013 Aug;19(9):1226-9. doi: 10.1177/1352458513481010. Epub 2013 Mar 18.
6
Global Hyperperfusion in the Brain at Onset of the Immune Reconstitution Inflammatory Syndrome in a Patient With Natalizumab-Associated PML.那他珠单抗相关进行性多灶性白质脑病患者免疫重建炎症综合征发作时脑内的全脑高灌注
Neurology. 2024 Oct 8;103(7):e209874. doi: 10.1212/WNL.0000000000209874. Epub 2024 Aug 30.
7
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.脑磁共振成像在那他珠单抗治疗的多发性硬化症患者药物警戒中的诊断性能
Mult Scler. 2016 Aug;22(9):1174-83. doi: 10.1177/1352458515615225. Epub 2015 Nov 12.
8
Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者中，严重的早期那他珠单抗相关进行性多灶性白质脑病合并免疫重建炎症综合征（PML-IRIS）对帕博利珠单抗的反应。
Mult Scler. 2024 May;30(6):760-762. doi: 10.1177/13524585241231655. Epub 2024 Feb 22.
9
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.MRI 标准区分纳武单抗药物警戒期间无症状 PML 与新 MS 病变。
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1138-45. doi: 10.1136/jnnp-2016-313772. Epub 2016 Aug 16.
10
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?马拉维若对患有那他珠单抗相关进行性多灶性白质脑病的多发性硬化症患者是否有用？
J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12.
引用本文的文献
1
Overview of MRI findings in progressive multifocal leukoencephalopathy.进行性多灶性白质脑病的磁共振成像表现概述
Jpn J Radiol. 2025 Jul 21. doi: 10.1007/s11604-025-01837-y.
2
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.进行性多灶性白质脑病与 JC 病毒相关疾病谱。
Nat Rev Neurol. 2021 Jan;17(1):37-51. doi: 10.1038/s41582-020-00427-y. Epub 2020 Nov 20.
Zotero 插件